{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:53:52Z","timestamp":1787738032725,"version":"build-2784847793"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Intermittent lower limb claudication limits function and quality of life. Supervised exercise programs are not readily available, and a noninvasive alternative is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess extracorporeal corporeal shockwave therapy in improving quality of life in patients with claudication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In this double-blind, placebo-controlled randomized clinical trial, patients in the outpatient setting at a single tertiary center for vascular surgery were randomized in a 1:1 ratio to extracorporeal shockwave therapy or placebo therapy with no shockwaves delivered. Recruitment was between June 2015 and January 2020, with 12-week follow-up ending in March 2020. A convenience sample of patients with claudication and conservative treatment requirements who refused or were unable to participate in supervised exercise were eligible. Patients receiving anticoagulation therapy or with an active cancer were excluded. Of 522 patients screened, 389 were eligible, 138 were enrolled, and 110 completed follow-up and were included in the primary analysis. Statistical analysis was completed by May 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>\n                      In the intervention group, patients received 100 impulses of 0.1mJ\/mm\/cm\n                      <jats:sup>2<\/jats:sup>\n                      in an area of the gastrocnemius muscle 3 times weekly for 3 weeks. The steps for treatment were replicated for the control group without delivering the treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the Physical Functioning domain of the 36-item Short-Form Quality of Life Questionnaire at 12-week follow-up. Secondary outcomes included walking distances, ankle brachial pressure index, and other quality-of-life measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 138 patients recruited and randomized, 92 (67%) were male, and the mean (SD) age of the study population was 67 (9.6) years. The intervention group had a significantly higher physical function score at 12 weeks (estimated median difference 3.8; 95% CI, 0.0-7.7;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.03). However, this significance did not remain when adjusting for covariates. At 12 weeks, the intervention group had significantly longer pain-free and maximum walking distances (pain-free estimated median difference, 34.1, 95% CI, 11.4-56.8;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.004; maximum estimated median difference, 51.4; 95% CI, 10.7-86.5;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>To our knowledge, this is the first double-blind, placebo-controlled, randomized clinical trial to consider extracorporeal shockwave therapy for the management of intermittent claudication. It demonstrated efficacy for walking distances, may have a positive effect on quality of life, and may provide a safe, noninvasive alternative therapy for patients with intermittent claudication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT02652078\">NCT02652078<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2024.0625","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T11:01:22Z","timestamp":1712746882000},"page":"625","source":"Crossref","is-referenced-by-count":6,"title":["Extracorporeal Shockwave for Intermittent Claudication and Quality of Life"],"prefix":"10.1001","volume":"159","author":[{"given":"Paris","family":"Cai","sequence":"first","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Pymer","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"},{"name":"Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Ibeggazene","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"},{"name":"Sheffield Hallam University, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Raza","sequence":"additional","affiliation":[{"name":"Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Hitchman","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"},{"name":"Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Chetter","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"},{"name":"Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Smith","sequence":"additional","affiliation":[{"name":"Academic Vascular Surgery Unit, Hull York Medical School, Hull, United Kingdom"},{"name":"Hull University Teaching Hospitals National Health Service Trust, Hull, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"soi240015r1","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"9901","key":"soi240015r2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"soi240015r3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2020-000897","article-title":"Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners.","volume":"6","author":"Harwood","year":"2020","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"6","key":"soi240015r4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1078-5884(97)80070-6","article-title":"Quality of life analysis in patients with lower limb ischaemia: suggestions for European standardisation.","volume":"13","author":"Chetter","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"508","key":"soi240015r5","first-page":"826","article-title":"The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study.","volume":"54","author":"Dumville","year":"2004","journal-title":"Br J Gen Pract"},{"issue":"3","key":"soi240015r6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor\u2019s choice\u20142017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"12","key":"soi240015r8","article-title":"Exercise for intermittent claudication.","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"soi240015r9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.jvs.2019.08.238","article-title":"National assessment of availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication.","volume":"71","author":"Dua","year":"2020","journal-title":"J Vasc Surg"},{"key":"soi240015r10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.avsg.2016.02.009","article-title":"A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication.","volume":"34","author":"Harwood","year":"2016","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"soi240015r11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jvn.2017.12.002","article-title":"Preferred exercise modalities in patients with intermittent claudication.","volume":"36","author":"Harwood","year":"2018","journal-title":"J Vasc Nurs"},{"issue":"5","key":"soi240015r12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/17085381211035259","article-title":"Provision of exercise services in patients with peripheral artery disease in the United Kingdom.","volume":"30","author":"Harwood","year":"2022","journal-title":"Vascular"},{"issue":"3","key":"soi240015r13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00264-008-0553-8","article-title":"Extracorporeal shock wave treatment in nonunions of long bone fractures.","volume":"33","author":"Xu","year":"2009","journal-title":"Int Orthop"},{"key":"soi240015r14","doi-asserted-by":"publisher","DOI":"10.1177\/1179572718765138","article-title":"Extracorporeal shock wave therapy in acute injury care: a systematic review.","volume":"7","author":"Zissler","year":"2018","journal-title":"Rehabil Process Outcome"},{"key":"soi240015r15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.avsg.2018.10.013","article-title":"Extracorporeal shockwave therapy for diabetic foot ulcers: a systematic review and meta-analysis.","volume":"56","author":"Hitchman","year":"2019","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"soi240015r16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.12968\/jowc.2023.32.3.182","article-title":"Extracorporeal shockwave therapy for diabetic foot ulcers: a feasibility study.","volume":"32","author":"Hitchman","year":"2023","journal-title":"J Wound Care"},{"issue":"1","key":"soi240015r17","first-page":"1","article-title":"Extracorporeal shock wave therapy for coronary artery disease: relationship of symptom amelioration and ischemia improvement.","volume":"6","author":"Takakuwa","year":"2018","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"1","key":"soi240015r18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12947-019-0163-1","article-title":"The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study.","volume":"17","author":"Celutkiene","year":"2019","journal-title":"Cardiovasc Ultrasound"},{"issue":"1","key":"soi240015r19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13063-017-1844-4","article-title":"Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial).","volume":"18","author":"Cayton","year":"2017","journal-title":"Trials"},{"issue":"2","key":"soi240015r20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jvs.2017.07.105","article-title":"A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication.","volume":"67","author":"Harwood","year":"2018","journal-title":"J Vasc Surg"},{"issue":"5","key":"soi240015r21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/1708538118773618","article-title":"Extracorporeal shockwave therapy for intermittent claudication: Medium-term outcomes from a double-blind randomised placebo-controlled pilot trial.","volume":"26","author":"Green","year":"2018","journal-title":"Vascular"},{"issue":"4","key":"soi240015r23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1358863X18762599","article-title":"Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.","volume":"23","author":"Gardner","year":"2018","journal-title":"Vasc Med"},{"key":"soi240015r24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.avsg.2017.06.133","article-title":"Extracorporeal Shockwave Therapy for Peripheral Arterial Disease: A Review of the Potential Mechanisms of Action.","volume":"45","author":"Raza","year":"2017","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"soi240015r25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/000331970505600407","article-title":"Effects of shock waves on microcirculation, perfusion, and pain management in critical limb ischemia.","volume":"56","author":"Belcaro","year":"2005","journal-title":"Angiology"},{"issue":"1","key":"soi240015r26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jvs.2008.08.011","article-title":"Quality of life in patients with lower limb ischemia; revised suggestions for analysis.","volume":"49","author":"Gulati","year":"2009","journal-title":"J Vasc Surg"},{"issue":"3","key":"soi240015r27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jvs.2023.03.497","article-title":"Lack of patient-centered evaluation of outcomes in intermittent claudication literature.","volume":"78","author":"O\u2019Banion","year":"2023","journal-title":"J Vasc Surg"},{"issue":"2","key":"soi240015r28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jvs.2009.01.042","article-title":"Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis.","volume":"50","author":"Nicola\u00ef","year":"2009","journal-title":"J Vasc Surg"},{"issue":"1","key":"soi240015r29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.114.007002","article-title":"Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease.","volume":"130","author":"McDermott","year":"2014","journal-title":"Circulation"},{"key":"soi240015r22","volume-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"soi240015r7","unstructured":"National Institute for Health and Care Excellence. Peripheral arterial disease: diagnosis and management. Accessed March 7, 2024. https:\/\/www.nice.org.uk\/guidance\/cg147"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2817239\/jamasurgery_cai_2024_oi_240015_1781556836.97111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:00:43Z","timestamp":1781622043000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2817239"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2024.0625","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}